The surgical sealants and adhesives market has been driven by technological advances, increasing numbers of surgical procedures, and a growing focus on effective wound closure. Over the years, chronic diseases have increasingly become prevalent, necessitating more surgical procedures. This includes sicknesses like cardiovascular problems, orthopedic problems, and different kinds of cancers that may require surgery to be treated. Technological advances have also influenced the market trends for surgical seals and adhesives. The reason behind this is that there are new generations of biomaterials, such as synthetic polymers and biodegradable compounds, that are more efficient and versatile. As a result, these enhancements improve not only the adhesive properties of the sealants but also reduce tissue damage, thus improving patient outcomes.
Additionally, due to the rising demand for minimally invasive surgeries, there is an increasing demand for surgical sealants and adhesives. With minimally invasive techniques continuing to be integrated in various medical disciplines, the need has arisen for sealants as well as adhesives, which can be used with precision and efficiency. Moreover, there is a shift towards the development of bio-based/biocompatible sealants and adhesives in this market industry. Manufacturers' increasing awareness about environmental sustainability and focus on patient safety has led them to seek eco-friendly options. Not only do they address these concerns, but they are compatible with human bodies, thereby minimizing adverse reactions.
Furthermore, strategic alliances, partnerships, and mergers dominate the competitive landscape of the surgical sealants & adhesive market. Major players in this field constantly engage in such ventures today to increase product portfolios and improve research/development capabilities while maximizing their global reach. By doing so, parties involved can leverage each other's strengths, thereby taking advantage of forthcoming opportunities arising from the changing healthcare environment. On the regulations front, stringent standards, together with approvals, control the introduction of new products into this marketplace; thus, manufacturers must adhere to those rules intended to ensure the safety/efficacy of their seals in the market. Consequently, continuous focus on research and development is observed in the sector for regulatory compliance to meet the highest quality standards.
Report Attribute/Metric | Details |
---|---|
Market Opportunities | Increasing surgical procedures, development of healthcare infrastructure and investments by industry players Key Market Drivers· Growing prevalence and incidence of various disorders· Growth in the number of accidents· Growth in the number of surgeries |
According to the research reports by MRFR, the global market for surgical sealants and adhesives is estimated to flourish at a healthy CAGR of over 10.4% to reach USD 6.51 billion over the assessment era 2023-2032.
Surgical sealants and adhesives are added to stitches to help prevent liquid and air leaks. They may also be used to replace staples and sutures for better closure, quicker implementation, a simpler and less painful procedure, and less blood loss without the need for removal.
In December 2023, RevBio, a US-based firm, obtained permission from the Food and Drug Administration (FDA) to start a first-in-human (FIH) clinical trial of its bone glue called Tetranite indicated cranial flap fixing, a synthetic substitute material for bonding human skull. The regulatory support and advances in materials are expected to drive innovation in the industry.
In June 2023, the U.S. Food and Drug Administration (FDA) authorized LiquiBandFix8 for Pre-Market Approval (PMA), a device that contains cyanoacrylate adhesive used during hernia surgery operations.
In May 2023, POWERSEALTM Sealer/Divider was launched by Olympus in many parts, including Europe.
In March 2023, Animus Surgical showed off a new transparent, biodegradable, non-toxic hydrogel wound sealant.
In January 2023, Grifols, one of the major players in plasma medicine, disclosed positive top-line results from its phase 3b study involving fibrin sealant (FS), which was aimed at treating bleeding that arose out of surgeries for pediatric patients. These positive results emanating from various studies and investigations conducted by key manufacturers will be essential for the introduction of novel products into the market.
In May 2022, Ethicon –a big player in this industry, acquired GATT Technologies based out of the Netherlands. This acquisition employs different synthetic polymers to design hemostatic and sealant products.
Ethicon is one of the leading surgical solutions providers that launched ENSEAL X1 Straight Jaw Tissue Sealer specifically in April 2022, targeting tissue sealing. Such product launches for tissue sealing would propel segment growth over the coming years.
In 2021, Ethicon purchased Tissuemed—a supplier of surgical sealant solutions—so as to expand its offering to surgeons outside the USA.
In recent years, the global market for surgical sealants and adhesives has grown dramatically. The increased frequency and incidence of numerous ailments around the world are largely responsible for the market's rise. Furthermore, one of the key factors driving the Surgical Sealants and Adhesives Market's expansion is the number of incidents. The escalating reported prevalence rates of numerous disorders such as obesity and cardiovascular disease (CVD), as well as the rising incidence of trauma and the number of accidents and sports-related injuries, have all contributed to an increase in surgical procedures performed worldwide. The necessity to manage blood loss in patients, as well as ongoing R&D to bring innovative products to market, are all contributing to Surgical Sealants and Adhesives Market growth. Surgical sealants and adhesives are becoming more widely used in aesthetic treatments due to improved cosmetic outcomes.
The global surgical sealants and adhesives market has been segmented into product, indication, application, and end user.
Based on product, has been segmented into natural/biological sealants and adhesives and synthetic and semisynthetic sealants and adhesives. The natural/biological sealants and adhesives and synthetic segment is accounted for the largest share segment of the market.
The market, by indication, has been segmented into surgical hemostasis, tissue sealing, and tissue engineering.
The market, by application, has been segmented into general surgeries, cardiovascular surgeries, central nervous system surgeries, orthopedic surgeries, urological surgeries, and others.
The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The surgical sealants and adhesives market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.
The European surgical sealants and adhesives market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.
The surgical sealants and adhesives market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The market in the Middle East & Africa has been segmented into the Middle East and Africa.
Some of the key players in the global surgical sealants and adhesives market are:
Regional Market Summary
Geographically, the Americas is anticipated to dominate the global surgical sealants and adhesives market owing to a well-developed healthcare sector, increasing surgeries, technological advancement, and rising geriatric population.
Europe is expected to hold the second largest position in the global surgical sealants and adhesives market. The market growth in this region is attributed to the increasing surgical procedures and developed healthcare infrastructure.
The surgical sealants and adhesives market in Asia-Pacific region consists of countries namely China, Japan, Republic of Korea, India, Australia and Rest of Asia-Pacific. The Asia-Pacific region is expected to be fastest growing region owing to the huge patient population of chronic diseases in the countries such as India and China.
The Middle East & Africa has the least share of the market. Majority of the market of this region is expected to be held by the Middle East region due to a well-developed healthcare sector and growing government initiatives for the healthcare sector.Recent Development
Recent Development
Intended Audience:
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)